PT949258E - Acido alfa-liponico em forma cristalina - Google Patents

Acido alfa-liponico em forma cristalina

Info

Publication number
PT949258E
PT949258E PT99104155T PT99104155T PT949258E PT 949258 E PT949258 E PT 949258E PT 99104155 T PT99104155 T PT 99104155T PT 99104155 T PT99104155 T PT 99104155T PT 949258 E PT949258 E PT 949258E
Authority
PT
Portugal
Prior art keywords
alpha
crystalline form
liponic acid
enantiomer
acid
Prior art date
Application number
PT99104155T
Other languages
English (en)
Portuguese (pt)
Inventor
Beisswenger Dr Thomas
Karl-Friedrich Landgraf
Matthias Rischer
Gunter Laban
Eberhard Oestreich
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of PT949258E publication Critical patent/PT949258E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Seasonings (AREA)
PT99104155T 1998-03-11 1999-03-02 Acido alfa-liponico em forma cristalina PT949258E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19810336A DE19810336A1 (de) 1998-03-11 1998-03-11 Alpha-Liponsäure mit neuartiger Modifikation
US09/074,645 US5994393A (en) 1998-03-11 1998-05-08 Alpha-lipoic acid with novel modification

Publications (1)

Publication Number Publication Date
PT949258E true PT949258E (pt) 2002-04-29

Family

ID=26044524

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99104155T PT949258E (pt) 1998-03-11 1999-03-02 Acido alfa-liponico em forma cristalina

Country Status (10)

Country Link
US (1) US5994393A (enExample)
EP (1) EP0949258B1 (enExample)
AT (1) ATE207914T1 (enExample)
CA (1) CA2265276C (enExample)
CY (1) CY1106435T1 (enExample)
DE (2) DE19810336A1 (enExample)
DK (1) DK0949258T3 (enExample)
ES (1) ES2164474T3 (enExample)
IN (1) IN186598B (enExample)
PT (1) PT949258E (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19834608A1 (de) * 1998-07-31 2000-02-03 Basf Ag Kristallmodifikation der Liponsäure
ES2259034T3 (es) * 2000-06-06 2006-09-16 Basf Aktiengesellschaft Uso de un enantiomero del acido lipoico en cosmeticos y dermatologicos.
DE10151764A1 (de) * 2001-10-19 2003-05-08 Basf Ag Kombination von Liponsäure und Glutamin in Lebens- und Arzneimitteln
US20090176864A1 (en) * 2004-11-24 2009-07-09 Hill's Pet Nutrition, Inc. Methods For Improving Hepatic and Immune Function In An Animal
ES2550952T3 (es) * 2004-11-24 2015-11-13 Hill's Pet Nutrition, Inc. Composición para su uso en la mejora del aclaramiento hepático de sustancias xenobióticas en un animal
AU2005322887B2 (en) 2004-12-30 2010-03-11 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
US8252742B2 (en) 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
BRPI0916476A2 (pt) * 2008-12-01 2016-02-16 Invasc Therapeutics Inc composição, método de tratamento para um distúrbio relacionado ao sistema renina-angiotensina-aldosterona, método para reduzir a resistência à insulina, método para tratar um distúrbio relacionado à síndrome metabólica
CN108484570B (zh) * 2018-05-15 2021-05-04 苏州富士莱医药股份有限公司 一种制备硫辛酸颗粒的方法及设备

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT95826B (pt) * 1989-11-09 1997-11-28 Asta Medica Ag Processo para a preparacao de composicoes farmaceuticas contendo como ingrediente activo acido r-alfa-liponico ou acido s-alfa-liponico
DE4218572A1 (de) * 1992-06-05 1993-12-09 Asta Medica Ag Synergistische Kombination von Arzneimitteln enthaltend als Wirkstoff alpha-Liponsäure, Dihydroliponsäure, deren Metaboliten sowie die oxidierten und reduzierten Enantiomere der alpha-Liponsäure wie die R-alpha-Liponsäure oder S-alpha-Liponsäure sowie Metaboliten der alpha-Liponsäure mit den Vitaminen A, B1-6, B12, C und E
DE4235912C2 (de) * 1992-10-23 2002-12-05 Viatris Gmbh Verfahren zur Herstellung kristalliner Thioctsäure und deren Verwendung
DE4433764A1 (de) * 1994-09-22 1996-03-28 Asta Medica Ag Darreichungsformen enthaltend alpha-Liponsäure, feste Salze von R-Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit

Also Published As

Publication number Publication date
ES2164474T3 (es) 2002-02-16
DK0949258T3 (da) 2002-01-28
US5994393A (en) 1999-11-30
DE59900364D1 (de) 2001-12-06
CA2265276C (en) 2009-09-08
IN186598B (enExample) 2001-10-06
ATE207914T1 (de) 2001-11-15
DE19810336A1 (de) 1999-09-23
EP0949258B1 (de) 2001-10-31
EP0949258A1 (de) 1999-10-13
CA2265276A1 (en) 1999-09-11
CY1106435T1 (el) 2011-04-06

Similar Documents

Publication Publication Date Title
WO2004011453A3 (en) Method for preparing 3-halo-4,5-dihydro-1h-pyrazoles
CA2349227A1 (en) Substituted 2-phenylbenzimidazoles, the production thereof and their use
AU5267286A (en) Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido) azabicycloalkanes
HUP0500084A3 (en) Encapsulation by coating with a mixture of lipids and hydrophobic, high melting point compounds
ATE207914T1 (de) Alpha-liponsäure in kristalliner form
NZ510070A (en) Crystalline forms of EtO2 C-CH2 -(R)Cgl-Aze-Pab-OH
IL140826A0 (en) Crystal modification of lipoic acid
MY133471A (en) Process for the preparation of racemic citalopram and s-or r-citalopram by separation of a mixture of r-and s-citalopram
ZA845833B (en) Anti-viral compositions
CA2503154A1 (en) A new crystalline form of the sodium salt of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid
ZA200207675B (en) Novel crystal form of pyrrolidylthiocarbapenem derivative.
JPS56131565A (en) 4-substituted-2-oxoazetidine compound and its preparation
BR0107743B1 (pt) processo para manufatura de grade positiva fina para baterias de chumbo ácidas e grade.
ATE35413T1 (de) Cephalosporinverbindungen und ihre herstellung.
PT1277750E (pt) Hidratos e cristais de um composto de acido neuraminico
EP0960879A3 (en) Improved process for the preparation of 5-aminotetrazole
AU2003285841A1 (en) A process for the preparation of crystalline form 1 or clopidogrel hydrogen sulfate
BR9808637A (pt) Compostos e método de preparação de ácidos 4-fenil-4 cianociclohexanóico
EP0954974A3 (en) Novel leavening acid composition
AU4411089A (en) Benzothiadiazepine derivatives
AU562643B2 (en) N-arylpiperazine derivatives
MA23268A1 (fr) Procede de preparation de composes azacyliques heterocycliques utiles comme antagonistes des recepteurs d'natagonisne ii.
JPS531699A (en) Production of basic chlorinated aluminum salt
PT1133496E (pt) Modificacao cristalina a de acido 8-ciano-1-ciclopropil-7-(1s,6s-2,8-diazabiciclo-¬4.3.0|nonan-8-il)-6-fluoro-1,4-di-hidro-4-oxo-3-quinolinocarboxilico
CA2366600A1 (en) A process for the preparation of 1,4,7,10-tetraazacyclododecane